Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASTORALE: KPL-387 in Recurrent Pericarditis
NCT07010159Phase 3Recruiting
- Sponsor
- Kiniksa Pharmaceuticals
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of KPL-387 in recurrent pericarditis, sponsored by Kiniksa Pharmaceuticals. Started Jul 2025; status: recruiting.
02
Drugs
KPL-387
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT07010159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07010159.